文献速递主动脉疾病颈动脉与弓上血管

胸主动脉腔内修复术中的脑栓塞保护

Cerebral embolic protection in thoracic endovascular aortic repair.
PubMed 文献 · J Vasc Surg · 2018-05-24

本研究为首次先导试验,10例解剖适合的患者在胸主动脉腔内修复术(TEVAR)中使用滤器式脑栓塞保护装置(CEPD),无卒中及装置相关并发症。9例可评估患者中7例(78%)出现新发弥散加权磁共振成像(DW-MRI)病灶,共检测2835个高信号瞬态信号(HITS),91%为气态、9%为固态。作者认为CEPD用于TEVAR安全可行,可能有助于减少脑损伤,气态栓塞的意义需进一步研究。

要点

  • TEVAR联合滤器式CEPD未发生卒中或装置相关并发症,中位增加手术时间7分钟。
  • 9例可评估患者中7例(78%)出现新发DW-MRI病灶,中位数量1个,中位表面积6 mm²。
  • 共检测2835个HITS,91%为气态、9%为固态;95%的滤器捕获到栓塞碎屑。

核心结论

  • 作者认为,CEPD联合TEVAR在这项首次先导研究中显得安全可行,可能作为减少脑损伤的有用辅助手段。
  • 气态栓塞的意义及其在TEVAR脑损伤中的作用值得进一步研究。

研究设计与样本

  • 首次先导研究,纳入解剖适合的10例患者(平均年龄68岁),在TEVAR术中使用滤器式脑栓塞保护装置(CEPD)。
  • 术中行经颅多普勒检测气态和固态高信号瞬态信号(HITS),术前及术后行DW-MRI,术后≤6个月行临床神经学评估。

主要发现

  • 无卒中或装置相关并发症发生。
  • CEPD中位增加手术时间7分钟(四分位距[IQR] 5-16分钟),增加透视时间3.3分钟(IQR 2.4-3.9分钟),增加总手术辐射2.2%。
  • CEPD的剂量面积乘积为1824 mGy·cm²(IQR 1235-3392 mGy·cm²),平均对比剂用量增加23 mL(IQR 24-35 mL)。
  • 9例可评估患者中7例(78%)出现新发DW-MRI病灶,多位于后脑,中位数量1个(IQR 1-3),中位表面积6 mm²(IQR 3-16 mm²)。
  • 7例患者共检测2835个HITS(91%气态、9%固态);CEPD操作时HITS最多为142个(IQR 59-146;95%气态、5%固态),支架释放时TEVAR中HITS最多为82个(IQR 73-142;81%气态、11%固态)。

局限性

  • 本研究为首次先导研究,样本量为10例患者,其中9例可评估DW-MRI。
  • 气态栓塞的意义及其在TEVAR脑损伤中的作用值得进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stroke occurs in 3% to 8% and silent cerebral infarction in >60% of patients undergoing thoracic endovascular aortic repair (TEVAR). We investigated the utility of a filter cerebral embolic protection device (CEPD) to reduce diffusion-weighted magnetic resonance imaging (DW-MRI) detected cerebral injury and gaseous and solid embolization during TEVAR. METHODS: Patients anatomically suitable underwent TEVAR with CEPD, together with intraoperative transcranial Doppler to detect gaseous and solid high-intensity transient signals (HITSs), pre- and postoperative DW-MRI, and clinical neurologic assessment ≤6 months after the procedure. RESULTS: Ten patients (mean age, 68 years) underwent TEVAR with a CEPD. No strokes or device-related complications developed. The CEPD added a median of 7 minutes (interquartile range [IQR], 5-16 minutes) to the procedure, increased the fluoroscopy time by 3.3 minutes (IQR, 2.4-3.9 minutes), and increased the total procedural radiation by 2.2%. The dose area product for CEPD was 1824 mGy·cm2 (IQR, 1235-3392 mGy·cm2). The average contrast volume used increased by 23 mL (IQR, 24-35 mL). New DW-MRI lesions, mostly in the hindbrain, were identified in seven of nine patients (78%). The median number was 1 (IQR, 1-3), with a median surface area of 6 mm2 (IQR, 3-16 mm2). A total of 2835 HITSs were detected in seven patients: 91% gaseous and 9% solid. The maximum number of HITSs were detected during CEPD manipulation: 142 (IQR, 59-146; 95% gaseous and 5% solid). The maximum number of HITSs during TEVAR occurred during stent deployment: 82 (IQR, 73-142; 81% gas and 11% solid). Solid HITSs were associated with an increase in surface area of new DW-MRI lesions (rs = 0.928; P = .01). Increased gaseous HITSs were associated with new DW-MRI lesions (rs = 0.912; P = .01), which were smaller (<3 mm; r = 0.88; P = .02). Embolic debris was captured in 95% of the filters. The median particle count was 937 (IQR, 146-1687), and the median surface area was 2.66 mm2 (IQR, 0.08-9.18 mm2). CONCLUSIONS: The use of a CEPD with TEVAR appeared to be safe and feasible in this first pilot study and could serve as a useful adjunct to reduce cerebral injury. The significance of gaseous embolization and its role in cerebral injury in TEVAR warrants further investigation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Grover G, Perera AH, Hamady M, et al. Cerebral embolic protection in thoracic endovascular aortic repair. J Vasc Surg. 2018. PMID: 29804744. doi:10.1016/j.jvs.2017.11.098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。